Plasma Renin Activity

Hormone/ Element

Report in 48Hrs

At Home

Fasting Required

Details

Renin hormone activity.

₹5,417₹7,738

30% OFF

Plasma Renin Activity (PRA) Test Information Guide

Why is it done?
- Measures the enzyme renin produced by the kidneys, which plays a crucial role in regulating blood pressure and fluid balance through the renin-angiotensin-aldosterone system (RAAS)
- Diagnose secondary hypertension (high blood pressure caused by underlying kidney or vascular disease) versus primary hypertension
- Evaluate patients with resistant hypertension or hypertension refractory to standard treatment
- Investigate unexplained hypokalemia (low potassium levels) or electrolyte abnormalities
- Assess renal artery stenosis (narrowing of blood vessels supplying the kidneys)
- Diagnose primary hyperaldosteronism (Conn's syndrome) when combined with plasma aldosterone level testing
- Monitor patients with chronic kidney disease or heart failure to assess RAAS activation
- Typically performed during initial hypertension workup or when secondary causes are suspected
Normal Range
- Normal Range Values: 0.5-4.0 ng/mL/hr (when upright/standing) or 0.3-1.9 ng/mL/hr (when supine/lying down), though reference values may vary by laboratory
- Units of Measurement: ng/mL/hr (nanograms per milliliter per hour) or mIU/L (milliunits per liter)
- Normal Results: Within the established reference range indicates normal renin production and appropriate regulation of the RAAS in response to body position and hydration status
- Elevated Renin (High): Results above 4.0 ng/mL/hr may indicate secondary hypertension, renal artery stenosis, or reduced renal perfusion
- Low Renin (Suppressed): Results below 0.5 ng/mL/hr may suggest primary hyperaldosteronism or essential hypertension with volume expansion
- Lab-specific reference ranges may vary; always consult your laboratory's reference values for accurate interpretation
Interpretation
- High Renin Activity Interpretation:
  - Suggests renal artery stenosis (renovascular hypertension)
  - Indicates secondary hypertension requiring further investigation
  - May reflect appropriate compensatory response to volume depletion or diuretic use
- Low Renin Activity Interpretation:
  - Indicates primary hyperaldosteronism when combined with elevated aldosterone levels
  - May reflect volume expansion or sodium retention
  - Suggests essential hypertension in many cases
- Factors Affecting Results:
  - Patient position: Upright position increases renin; supine position decreases renin
  - Medications: ACE inhibitors, ARBs, diuretics, and NSAIDs can elevate renin levels
  - Salt intake: High sodium diet suppresses renin; low sodium diet increases renin
  - Time of day: Renin levels vary diurnally (circadian rhythm)
  - Hydration status and plasma volume
  - Age: Renin levels typically decrease with increasing age
  - Pregnancy: Renin levels increase during pregnancy
- Clinical Significance:
  - Elevated renin with elevated aldosterone suggests primary hyperaldosteronism requiring specific treatment
  - Elevated renin with low aldosterone indicates secondary hyperaldosteronism or renovascular disease
  - Suppressed renin with elevated aldosterone confirms primary hyperaldosteronism
  - Test often performed with plasma aldosterone level and aldosterone-renin ratio for comprehensive RAAS assessment
Associated Organs
- Primary Organs Involved:
  - Kidneys: Produce renin from juxtaglomerular cells in response to decreased blood pressure and sodium levels
  - Adrenal glands: Produce aldosterone in response to renin, regulating sodium and potassium balance
  - Blood vessels: Angiotensin II (formed via renin pathway) causes vasoconstriction affecting blood pressure
  - Heart: Affected by blood pressure and electrolyte changes regulated by the RAAS
- Conditions Associated with Abnormal Results:
  - Renal artery stenosis (narrowing of renal arteries)
  - Primary hyperaldosteronism (Conn's syndrome)
  - Chronic kidney disease
  - Congestive heart failure
  - Hepatic cirrhosis with ascites
  - Diabetic kidney disease
  - Hypovolemia or dehydration
- Diseases Diagnosed or Monitored:
  - Resistant hypertension
  - Secondary hypertension
  - Renovascular hypertension
  - Electrolyte disorders (hypokalemia)
- Potential Complications with Abnormal Results:
  - Persistent hypertension leading to myocardial infarction, stroke, or end-organ damage
  - Progressive renal insufficiency if underlying kidney disease remains untreated
  - Severe electrolyte imbalances affecting cardiac and neurological function
  - Cardiac arrhythmias if potassium levels are severely altered
Follow-up Tests
- Commonly Recommended Follow-up Tests:
  - Plasma aldosterone level: To calculate aldosterone-renin ratio and assess for hyperaldosteronism
  - Aldosterone-renin ratio (ARR): Screening test for primary hyperaldosteronism when ratio is >30
  - Renal artery duplex ultrasound: To detect renal artery stenosis
  - CT or MR angiography: Non-invasive imaging to visualize renal arteries for stenosis
  - Captopril renin test: Provocative test to enhance renin response in suspected renovascular disease
  - Saline suppression test: Confirmatory test for primary hyperaldosteronism
- Additional Investigations Based on Results:
  - Renal function tests (creatinine, BUN): Assess kidney function and glomerular filtration rate
  - Electrolyte panel (sodium, potassium, chloride): Evaluate for imbalances
  - 24-hour urine aldosterone: More sensitive test for hyperaldosteronism diagnosis
  - Renal vein renin sampling: Invasive test distinguishing unilateral from bilateral disease
  - Cardiac imaging (echocardiogram): Assess for left ventricular hypertrophy or heart failure
  - Adrenal imaging (CT or MRI): If adrenal adenoma suspected on hormone testing
- Monitoring Frequency:
  - For suspected secondary hypertension: Initial evaluation with single test; repeat if diagnosis uncertain after treatment
  - For hyperaldosteronism monitoring: Repeat testing after starting treatment to confirm suppression
  - For chronic kidney disease: Monitor annually or as clinically indicated
  - For heart failure: Assess periodically based on clinical response to therapy
Fasting Required?
- Fasting Status: No - Fasting is NOT required for plasma renin activity testing
- Special Pre-test Instructions:
  - Patient positioning: Must remain upright (sitting or standing) for 30 minutes before blood draw, or supine (lying down) for 60 minutes depending on protocol
  - Exact position should be specified when ordering and reported with results
- Medications to Avoid or Modify:
  - Ideally discontinue ACE inhibitors and ARBs for 2-4 weeks prior to testing
  - Discontinue diuretics for 2-4 weeks if possible to avoid stimulating renin
  - Avoid NSAIDs (non-steroidal anti-inflammatory drugs) for several days before testing
  - Discontinue beta-blockers if medically safe, as they suppress renin
  - Avoid potassium-sparing diuretics and aldosterone antagonists
  - Licorice consumption should be avoided for 2 weeks prior to testing as it affects aldosterone
  - Consult with physician before stopping any medications
- Dietary Considerations:
  - Maintain normal sodium diet during the week before testing (neither excess nor restriction)
  - Some labs recommend a low-sodium diet (50-100 mEq/day) for 3 days before testing to stimulate renin
  - Adequate hydration is important; drink normal amounts of water
  - Avoid caffeine and stimulants on the morning of the test as they can affect results
- Additional Patient Preparation:
  - Rest for 30 minutes before blood draw in prescribed position
  - Drawing should be done in early morning (typically 7-8 AM) to maintain circadian rhythm consistency
  - Avoid physical activity or exercise immediately before testing
  - Blood must be collected in EDTA or lithium heparin tube and kept on ice
  - Sample must be transported immediately to laboratory on ice and processed promptly
  - Inform healthcare provider of any medications you are taking, as they may affect results

How our test process works!